NCT01958528View on ClinicalTrials.gov

Study Of Circulating Multiple Myeloma Cells As A Biomarker of MGUS And SMM

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

May 23, 2013

Primary Completion Date

January 11, 2019

Study Completion Date

January 22, 2019

Conditions
a Diagnosis of MGUS or SMM by IMWG Criteria
Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT01958528 - Study Of Circulating Multiple Myeloma Cells As A Biomarker of MGUS And SMM | Biotech Hunter | Biotech Hunter